Science Explorer Interactive view Map
Company · Shanghai · China

Lilly (China)

lillychina.comROR OpenAlex
World rank, all time
#32,452
of 42,892
Rank in China
#3,050
of 3,536
Research works
133
▼ 2% vs 2013–17
Citations
2.9k
21.7 per fractional work
Top-10% rate
11.3%
record average 16.5%
Open access
46%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.94× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 4.40× its world share, 1 worksImmunology and Micro…Neuroscience: 1.93× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.51× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.47× its world share, 1 worksChemistryEngineering: 0.11× its world share, 0 worksEngineeringMaterials Science: 0.16× its world share, 0 worksMaterials ScienceMathematics: 0.50× its world share, 0 worksMathematicsHealth Professions: 0.48× its world share, 0 worksHealth ProfessionsMedicine: 3.42× its world share, 13 worksMedicineDecision Sciences: 0.16× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.59× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.5×. Every wedge is a field page.

Which keywords describe research at Lilly (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Breast Cancer, Diabetes, Glycemic Control, Insulin Therapy, Obesity, Metastatic Breast Cancer, Neurological Disorders and Cell Cycle Control.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Breast Cancer2▲ 45×6 topics
  2. Diabetes2▲ 20×5 topics
  3. Glycemic Control2▲ 54×4 topics
  4. Insulin Therapy2▲ 66×3 topics
  5. Obesity2▲ 10×7 topics
  6. Cardiovascular Disease1▲ 6.1×4 topics
  7. Metastatic Breast Cancer1▲ 127×2 topics
  8. Neurological Disorders1▲ 12×4 topics
  9. Cell Cycle Control1▲ 221×2 topics
  10. CDK4/6 Inhibitors1▲ 234×1 topic
  11. Chemotherapy1▲ 8.8×8 topics
  12. Clinical Trials1▲ 8.7×6 topics
  13. Epidemiology1▲ 1.49×10 topics
  14. Inflammation1▲ 3.0×12 topics
  15. Palbociclib1▲ 234×1 topic
  16. Type 2 Diabetes1▲ 27×2 topics
  17. Type 1 Diabetes1▲ 64×2 topics
  18. Cardiovascular Risk1▲ 17×3 topics
  19. Headache Disorders1▲ 213×1 topic
  20. Migraine1▲ 125×1 topic
  21. Neoadjuvant Therapy1▲ 22×3 topics
  22. Radiotherapy1▲ 13×3 topics

Which research topics does Lilly (China) publish most on?

By volume in 2022–2025: Advanced Breast Cancer Therapies, Migraine and Headache Studies, Diabetes Management and Research and Breast Cancer Treatment Studies.

Advanced Breast Cancer Therapies: 1 fractional worksMigraine and Headache Studies: 1 fractional worksDiabetes Management and …1Diabetes Management and Research: 1 fractional worksBreast Cancer Treatment …1Breast Cancer Treatment Studies: 1 fractional worksDiabetes Treatment and Management: 1 fractional worksSpondyloarthritis Studies and Treatments: 0 fractional worksBariatric Surgery and Ou…0Bariatric Surgery and Outcomes: 0 fractional worksPsoriasis: Treatment and…0Psoriasis: Treatment and Pathogenesis: 0 fractional worksLung Cancer Treatments a…0Lung Cancer Treatments and Mutations: 0 fractional worksRheumatoid Arthritis Res…0Rheumatoid Arthritis Research and Therapies: 0 fractional works
Pulmonary and Respiratory MedicinePsychiatry and Mental healthEndocrinology, Diabetes and MetabolismCancer Research3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  2. 2 Migraine and Headache Studies Psychiatry and Mental health 1 works
  3. 3 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
  4. 4 Breast Cancer Treatment Studies Cancer Research 1 works
  5. 5 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  6. 6 Spondyloarthritis Studies and Treatments Rheumatology 0 works
  7. 7 Bariatric Surgery and Outcomes Surgery 0 works
  8. 8 Psoriasis: Treatment and Pathogenesis Immunology 0 works
  9. 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  10. 10 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.2%not open53.8%

World: 28% of research is openly available.

with international co-authors55.0%domestic only45.0%

World: 19% is written across borders.

How has Lilly (China)'s research output changed?

Output in 2018–2022 was 2% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Shanghai

All research institutions in Shanghai

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.